Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio
Kenneth L. Dorsney, Editor-in-Chief 1,035 pages Buy from Amazon Pre-ANDA litigation is the companion to ANDA Litigation, which I recommend […]
Kenneth L. Dorsney, Editor-in-Chief 1,035 pages Buy from Amazon Pre-ANDA litigation is the companion to ANDA Litigation, which I recommend […]
Pharmaceutical life cycle management begins earlier and ends later to maximize stakeholder value in all phases of drug development.
How Pharmaceutical Life Cycle Management Strategies Are Evolving Read Post »
For readers following the the Biologic Patent Transparency Act, DrugPatentWatch has recently been cited in an article describing the act as
DrugPatentWatch in the news: The Biologic Patent Transparency Act. Read Post »
This paper was originally published by Reed F. Beall, Jason W. Nickerson, Warren A. Kaplan, Amir Attaran in PLoS ONE
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products? Read Post »
Healthcare systems including hospitals are taking care-related and business-related steps to cope with rapidly increasing drug prices.
Rising Drug Prices: How Healthcare Systems Are Coping Read Post »
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Kenneth L. Dorsney, Editor-in-Chief 985 pages (4 pounds!) Buy from Amazon
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Read Post »
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
How Companies Can Extract Value from Expired Drug Patents Read Post »
According to the Louisiana Department of Health, an estimated 500 people per year are infected with hepatitis C (HCV) in Louisiana. By
A ‘Netflix’ Model for Drug Pricing to Bring Treatments to More People Read Post »
Successful drug patent challengers get 180 days of market protection The Food and Drug Administration rewards successful drug patent challengers
Day 181 Generic Drug Launch – A Fast and Cheap Way to Find Generic Entry Opportunities Read Post »